Alf Giese

Medicine · Health Sciences

46h-index6.7kcitations168works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(43), Spinal Fractures and Fixation Techniques(26), Spine and Intervertebral Disc Pathology(22), Intracranial Aneurysms: Treatment and Complications(11), Cell Adhesion Molecules Research(11)

Publications167 total

Targeted attack: Harnessing myelin-specific plasmolipin for suppression of neuroblastoma and glioblastoma
Molecular Therapy Oncology·2026Open Access
Transcriptomic biomarkers in biomedicine
Elsevier eBooks·2025
Translational transcriptomics for personalized oncology
Elsevier eBooks·2025
Contributors
Elsevier eBooks·2025
Molecular pathway approach in clinical oncology
Elsevier eBooks·2024
Contributors
Elsevier eBooks·2024Open Access
Concurrent Activation of Both Survival-Promoting and Death-Inducing Signaling by Chloroquine in Glioblastoma Stem Cells: Implications for Potential Risks and Benefits of Using Chloroquine as Radiosensitizer
Cells·2023· 8 citedOpen Access
Supplemental Tables 2-6 from Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase
2023Open Access
Supplemental Tables 2-6 from Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase
2023Open Access
supplemental figures from Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase
2023Open Access
Data from Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase
2023Open Access
Suppl. Table 1 from Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase
2023Open Access
Data from Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase
2023Open Access
supplemental figures from Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase
2023Open Access
Suppl. Table 1 from Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase
2023Open Access
Gamma Irradiation Triggers Immune Escape in Glioma-Propagating Cells
Cancers·2022· 1 citedOpen Access
Algorithmically Deduced FREM2 Molecular Pathway Is a Potent Grade and Survival Biomarker of Human Gliomas
Cancers·2021· 18 citedOpen Access
Case of multifocal glioblastoma with four fusion transcripts of <i>ALK</i>, <i>FGFR2</i>, <i>NTRK2</i>, and <i>NTRK3</i> genes stresses the need for tumor tissue multisampling for transcriptomic analysis
Molecular Case Studies·2021· 14 citedOpen Access
Correction to: Effect of irrigation on fibrinolytic rtPA therapy in a clot model of intracerebral haemorrhage: a systematic in vitro study
Acta Neurochirurgica·2020Open Access
Clinical use of RNA sequencing and oncobox analytics to predict personalized targeted therapeutic efficacy.
Journal of Clinical Oncology·2020· 11 cited
page 1 of 9Next →

Frequent Co-authors

Michael E. Berens(12), Sven R. Kantelhardt(9), Sven Rainer Kantelhardt(6), Veit Rohde(6), Melinda A. Loo(5), Angelika Gutenberg(5), Ella Kim(5), Stephen W. Coons(4), Wendy S. McDonough(4), Mirjam Renovanz(4), Jan Leppert(4), Ella L. Kim(4), Nhan L. Tran(3), Monique D. Rief(3), Christian Beaudry(3), Dominique B. Hoelzinger(3), Naureen Keric(3), Elżbieta Kaczmarek(3), Manfred Westphal(3), Anton Buzdin(3)